Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments.

De Groot, S

Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments. [electronic resource] - PloS one 2017 - e0177364 p. digital

Publication Type: Comparative Study; Journal Article

1932-6203

10.1371/journal.pone.0177364 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Agents--economics
Carcinoma, Renal Cell--drug therapy
Cost of Illness
Cost-Benefit Analysis
Female
Humans
Indoles--economics
Kidney Neoplasms--drug therapy
Male
Middle Aged
Neoplasm Metastasis
Netherlands
Pyrroles--economics
Quality-Adjusted Life Years
Registries
Regression Analysis
Sunitinib
Treatment Outcome
Young Adult